Trexquant Investment’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
NAMI
B
Trexquant Investment's NEO Position: Q2 2026 in Review
Trexquant Investment increased its NeoGenomics (NEO) stake by 1,089% in Q2 2026, buying an estimated $3.85M and bringing the position to 435,783 shares worth $6.36M. The position accounts for 0.04% of the portfolio, ranked #619.
Trexquant Investment first reported a position in NEO in Q2 2016 and has held it in 21 quarters since. The position peaked at $10.4M in Q4 2025. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Trexquant Investment held 435,783 shares of NeoGenomics worth $6.36M as of Q2 2026.
- Trexquant Investment bought 399,119 NeoGenomics shares in Q2 2026, an estimated $3.85M.
- NeoGenomics made up 0.04% of Trexquant Investment's portfolio in Q2 2026, its #619 holding.
- Trexquant Investment first reported a position in NeoGenomics in Q2 2016 and has held it in 21 quarters since.
- Trexquant Investment's NeoGenomics position peaked at $10.4M in Q4 2025.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.